Healthcare Leader: Stay Informed: Avian Flu Surveillance, Vaccine Audio Series, Upcoming Office Hours and More!

May 2, 2024

CDC's Surveillance Efforts: Avian Influenza A (H5N1)

The Centers for Disease Control and Prevention (CDC) provides a weekly update on its efforts to monitor influenza data to help the public better comprehend the current situation with avian influenza A (H5N1). Cases of novel influenza, where individuals are infected with non-human influenza A viruses different from currently circulating seasonal human flu viruses, are considered nationally notifiable. The CDC comprehensively investigates and reports on each identified novel influenza case. Click here to view the latest weekly snapshot.

Latest Vaccine Resources

New Vaccine Voices Audio Sessions Available on IPRO's Immunization Microsi te

This 6-part audio series delves into Motivational Interviewing (MI) techniques to foster vaccine acceptance in long-term care. Each 20-minute module features real-life scenarios and expert insights.

Episode 1: "Are Vaccines Still Necessary?"
Episode 2: "I Don't Want to Upset My Family"
Episode 3: "I Can't Afford to Miss Work"
Episode 4: "Why Should I Trust You Now?"
Episode 5: "You Can't Put Those Chemicals in My Sick Child"
Episode 6: "You're Doing Their Work for Them"

Listen in as each episode tackles common hesitancy scenarios. Don't miss out on these valuable insights. Visit the Vaccine Voices page to start listening today.

COVID-19 Snapshot: New CDC Recommendations

Check Your Community's Stats

Who's Considered Up To Date?

Meningococcal Vaccines: Recommendations and Considerations for Adults

Q: What meningococcal vaccines are recommended for adults?

A: The CDC recommends the MenACWY vaccine for adults with certain medical conditions or increased risk factors, such as complement deficiencies, complement inhibitor use, asplenia, HIV, microbiologists exposed to Neisseria meningitidis (N. meningitidis), travel to high-risk areas, or during outbreaks. The MenB vaccine is also recommended for adults in those same high-risk groups.

Q: Who might not be able to get meningococcal vaccines?

A: Individuals who have had a life-threatening allergic reaction to a previous dose or severe allergy to vaccine components should not receive that particular meningococcal vaccine. Pregnant or breastfeeding women should discuss risks and benefits with their doctor before getting MenB or MenABCWY vaccines. Those with moderate to severe illness should wait until recovered.

Upcoming Office Hours

IP3-Office Hours for Infection Preventionists

Don't miss our lively IP3 group chat, happening every Thursday at 11am ET. Hosted by infection prevention pros Melanie Ronda, MSN, RN and Mary Ellen Casey, MSN, RN. Join us to swap new ideas, discover innovative approaches, and collaborate with your fellow IPs.

Navigating NHSN: Stay Up-to-Date

The IPRO QIN-QIO is hosting a 30-minute, bi-weekly chat to discuss various topics surrounding NHSN including official NHSN updates, reminders about upcoming changes, and answers to our most commonly received provider questions. Bring your questions and concerns and learn to better navigate NSHN.

Stay informed about vaccine updates:

Visit our WAVE page to access up-to-date resources to support your efforts

Keep the learning going:

Visit our cal enda r to register for upcoming events
Access on-demand training with IPRO Learn!

For questions or technical assistance:

Visit our website
Email us
Call us toll-free at 888-502-0566

Visit Our Resource Library

Join Our Network

www.qi.ipro.org

The IPRO QIN-QIO works to ensure high-quality, safe health care in New England, New York, New Jersey, Ohio, Delaware, Maryland, and the District of Columbia.

This material was prepared by the IPRO QIN-QIO, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this document do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. 12SOW-IPRO-QIN-T1-AA-21-435